Literature DB >> 24407539

The fourth-generation Calcium channel blocker: cilnidipine.

K Sarat Chandra1, G Ramesh2.   

Abstract

Several classes of antihypertensive agents have been in clinical use, including diuretics, α-blockers, β-blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin II type 1 receptor blockers (ARB), and organic calcium channel blockers (CCBs). All these drugs are being currently used in the treatment of Hypertension & various disease conditions of the heart either alone or in combination. Cilnidipine is a new antihypertensive drug distinguished from other L-type Ca(2+) channel blockers or even other antihypertensives, which will be useful for selection of antihypertensive drugs according to the pathophysiological condition of a patient.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24407539      PMCID： PMC3905258          DOI： 10.1016/j.ihj.2013.11.001

Source DB:  PubMed          Journal:  Indian Heart J        ISSN： 0019-4832


  44 in total

1.  Nomenclature of voltage-gated calcium channels.

Authors:  E A Ertel; K P Campbell; M M Harpold; F Hofmann; Y Mori; E Perez-Reyes; A Schwartz; T P Snutch; T Tanabe; L Birnbaumer; R W Tsien; W A Catterall
Journal:  Neuron       Date:  2000-03       Impact factor: 17.173

2.  Neuronal Ca2+ channel blocking action of an antihypertensive drug, cilnidipine, in IMR-32 human neuroblastoma cells.

Authors:  Akira Takahara; Shin-ichi Fujita; Keiko Moki; Yukitsugu Ono; Hajime Koganei; Satoshi Iwayama; Hiroshi Yamamoto
Journal:  Hypertens Res       Date:  2003-09       Impact factor: 3.872

Review 3.  The first Irvine H. Page lecture. The mosaic of hypertension: past, present and future.

Authors:  E D Frohlich
Journal:  J Hypertens Suppl       Date:  1988-12

4.  Cilnidipine is as effective as benazepril for control of blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis.

Authors:  G W Rose; Y Kanno; H Ikebukuro; M Kaneko; K Kaneko; T Kanno; Y Ishida; H Suzuki
Journal:  Hypertens Res       Date:  2001-07       Impact factor: 3.872

5.  Comparison between valsartan and valsartan plus cilnidipine in type II diabetics with normo- and microalbuminuria.

Authors:  K Katayama; S Nomura; H Ishikawa; T Murata; S Koyabu; T Nakano
Journal:  Kidney Int       Date:  2006-05-17       Impact factor: 10.612

6.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

Authors:  Guruprasad Manjunath; Hocine Tighiouart; Hassan Ibrahim; Bonnie MacLeod; Deeb N Salem; John L Griffith; Josef Coresh; Andrew S Levey; Mark J Sarnak
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

Review 7.  [Dihydropyridines from the first to the fourth generation: better effects and safety].

Authors:  Karim Aouam; Alain Berdeaux
Journal:  Therapie       Date:  2003 Jul-Aug       Impact factor: 2.070

Review 8.  [Hypertension 2007-2008].

Authors:  Christos Chatzikyrkou; Jan Menne; Hermann Haller
Journal:  Med Klin (Munich)       Date:  2009-08-23

Review 9.  Calcium channel blockers: differences between subclasses.

Authors:  William H Frishman
Journal:  Am J Cardiovasc Drugs       Date:  2007       Impact factor: 3.571

10.  Excellent tolerance to cilnidipine in hypertensives with amlodipine - induced edema.

Authors:  Ranjan Shetty; G Vivek; Kushal Naha; Anil Tumkur; Abhinav Raj; K L Bairy
Journal:  N Am J Med Sci       Date:  2013-01
View more
  6 in total

1.  A Comparative Study on Clinical and Biochemical Parameters in Amlodipine and Cilnidipine Treated Hypertensive Patients.

Authors:  Kiran Shetty; Ranjan Shetty; Lakshminarayana Bairy; Pragna Rao; Amruth Kiran; Manjunath Shetty; Vidya Nayak
Journal:  J Clin Diagn Res       Date:  2017-05-01

2.  An Open Label Parallel Group Study to Assess the Effects of Amlodipine and Cilnidipine on Pulse Wave Velocity and Augmentation Pressures in Mild to Moderate Essential Hypertensive Patients.

Authors:  Rama Mohan Pathapati; Sujith Tumkur Rajashekar; Madhavulu Buchineni; Rajesh Kumar Meriga; Chirra Bhakthavasthala Reddy; Kolla Praveen Kumar
Journal:  J Clin Diagn Res       Date:  2015-11-01

3.  Comparison of Plasma Levels of Renin, Vasopressin and Atrial Natriuretic Peptide in Hypertensive Amlodipine Induced Pedal Oedema, Non-Oedema and Cilnidipine Treated Patients.

Authors:  Kiran Shetty; Ranjan Shetty; Pragna Rao; Mamatha Ballal; Amruth Kiran; Sravan Reddy; Umesh Pai; Jyothi Samanth
Journal:  J Clin Diagn Res       Date:  2017-06-01

Review 4.  New generations of dihydropyridines for treatment of hypertension.

Authors:  Angela L Wang; Costantino Iadecola; Gang Wang
Journal:  J Geriatr Cardiol       Date:  2017-01       Impact factor: 3.327

5.  Vasorelaxant effects of Angelica decursiva root on isolated rat aortic rings.

Authors:  Bumjung Kim; Youngki Kwon; Somin Lee; Kyungjin Lee; Inhye Ham; Ho-Young Choi
Journal:  BMC Complement Altern Med       Date:  2017-10-02       Impact factor: 3.659

Review 6.  Is dental plaque the only etiological factor in Amlodipine induced gingival overgrowth? A systematic review of evidence.

Authors:  Sumit Gaur; Rupali Agnihotri
Journal:  J Clin Exp Dent       Date:  2018-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.